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A One-Step Recipe for Pancreatic Beta Cells
PAGE 449
Type I and II diabetes ultimately result in the loss of insulin-producing beta cells in the pancreas. Current attractive therapeutic
strategies aim at replacing these cells by using stem or progenitor cells differentiated in vitro. Using a transgenic approach,
Collombat et al. now reveal that ectopic expression of the Pax4 gene in diverse endocrine cell subtypes, including alpha cells,
induces a continuous conversion of progenitor cells into functional beta cells. These transdifferentiated cells are functional
and can reverse the consequences of chemically induced type I diabetes in vivo. Thus, making new beta cells from pre-
existing latent stem/progenitor cells and alpha cells may be a new avenue for therapy.
A Homegrown Ligand for PPARa
PAGE 476
The nuclear receptors known as PPARsmodulate metabolic and inflammatory pathways
by responding to nutritional signals through ligand activation of transcription. They are
the targets of drugs in use and in development for disease therapy. No authentic endog-
enous PPAR ligand (the molecule that occupies the nuclear receptor binding site in vivo
while the receptor is actively driving transcription) has been identified. Chakravarthy et al.
now provide evidence that endogenous lipid synthesis generates a discrete phosphati-
dylcholine species that serves as an endogenous ligand for PPARa.
Telomerase: Length Doesn’t Matter
PAGE 463
A central question in telomere biology concerns how telomerase maintains telomere
length. Many studies have suggested that telomerase is preferentially recruited to the shortest telomeres. However, Zhou
et al. now show that under telomere length-maintenance conditions in human cancer cells, telomerase extends the vast
majority of chromosome ends irrespective of length. The authors also find that extension of the chromosome end by telome-
rase after telomere replication is both mechanistically and temporally distinct from filling-in of the extended single-stranded
overhang. These results reveal new steps in human telomere maintenance and may have important implications for both
cancer and aging.
Transcription, One Cycle at a Time
PAGE 489
Eukaryotic transcription is a dynamic process relying on a large number of proteins. By measuring the cycling expression of
the pyruvate dehydrogenase kinase 4 gene in human cells, Degenhardt et al. now construct a detailed stochastic model for
single-gene transcription at the molecular level using realistic kinetics for diffusion and protein complex dynamics. The model
can predict the precise timing of single-gene activity that leads to transcriptional cycling on the cell population level when
taking into account the sequential and irreversible multistep nature of transcriptional initiation. This systems biology approach
proposes that the cyclic nature of population gene expression is primarily based on the intrinsic periodicity of the transcription
process itself.
Chromatin Tailors a Spindle to Fit
PAGE 502
The mitotic spindle is a bipolar structure made of microtubules and is required for chromosome
segregation prior to cell division. Using microfabricated chromatin-coated beads to form patterns
of chromatin that differ in size and shape, Dinarina et al. now systematically characterize the
dynamics in spindle assembly, shape, and polarity as a function of chromatin mass. Their results
demonstrate that chromatin size and shape defines spindle shape and orientation.
Controlling Chloride Cotransporters
PAGE 525
Modulation of the intracellular chloride concentration via K-Cl cotransporters plays a funda-
mental role in diverse processes, including the regulation of cell volume and neuronal excitation. Rinehart et al. now apply
cutting-edge techniques in phosphoproteomics to identify two conserved phosphorylation sites that control K-Cl cotrans-
porter activity. These sites are rapidly dephosphorylated in response to osmotic stress, and their mutation to alanines
results in constitutive transporter activity. These sites also show regulated phosphorylation in red blood cells and neurons.
The authors go on to identify candidate controlling kinases, providing new insights into the regulation of cell volume and
neuronal function.Cell 138, August 7, 2009 ª2009 Elsevier Inc. 405
Second SH2 Site Specifies Signaling Specificity
PAGE 514
Receptor tyrosine kinases (RTKs) control many important cellular processes by acti-
vating intracellular signaling pathways through the recruitment and phosphorylation of
signaling proteins containing SH2 domains. These domains recognize phosphotyrosine
(pY) in the context of particular sequence motifs in receptor phosphorylation sites. Bae
et al. now provide evidence that in vivo signaling selectivity for the interaction between
the FGFR1 RTK and phospholipase Cg is determined by additional phosphorylation-
independent interactions between the RTK kinase domain and a secondary SH2 binding
site. The findings reveal a mechanism for ensuring signaling specificity in the midst of
numerous possible SH2-RTK cellular interactions.
Cargo Is a Myosin Matchmaker
PAGE 537
Myosin VI is unique among uncoventional myosins in its ability to move to the minus end
of actin filaments. Although mobile as monomers, the processive walking of unconventional myosins on filaments requires
dimerization of the motors. Yu et al. now show that myosin VI uses an unanticipated mechanism for dimerization. The authors
apply several techniques to solve the structures of the myosin VI tail cargo binding domain in its free and cargo-bound
forms. The structures reveal that myosin VI undergoes a cargo-mediated monomer to dimer conversion, providing a new
and potentially broadly utilized mechanism in the regulation of myosin motor processitivity.
The ER Gets Hooked Up, Atlast
PAGE 549
Cellular organelles have characteristic shapes. For example, the endoplasmic reticulum (ER), which is responsible for the
synthesis of lipids or secreted proteins (such as insulin), consists of tubules and sheets. Previous work had identified proteins
that shape the tubules. Hu et al. now demonstrates that additional proteins are required to interconnect the tubules to form
a polygonal network. These proteins—atlastins in mammals and Sey1 p in yeast—are membrane-bound GTPases that
belong to the dynamin family. Mutations in atlastin-1 cause a common form of hereditary spastic paraplegia, suggesting
that defects in ER morphology may underlie the disease.
IRE1a at the Crossroads of Splicing and Apoptosis
PAGE 562
Endoplasmic reticulum (ER) stress triggers the unfolded protein response (UPR), an adaptive pathway that increases the ER’s
folding capacity. If homeostasis is not restored, the UPR induces apoptosis. Han et al. now identify the ER transmembrane
kinase/endoribonuclease (RNase) IRE1a as a key component of this apoptotic switch. Besides splicing XBP1 mRNA to
promote adaptation to ER stress, IRE1a activated by autophosphorylation also degradesmany ER-localizedmRNAs, thereby
promoting apoptosis. Using chemical genetics, the authors show that kinase inhibitors blocking IRE1a autophosphorylation
can activate the RNase activity of IRE1a via an alternate mode that enforces XBP1 splicing, averts mRNA decay and
apoptosis, and may have important therapeutic ramifications.
RNA Polymerase Battles Foreign DNA in the Cytoplasm
PAGE 576
Delivery of double-strandedDNA into a cell’s cytoplasmcan trigger the potent induction of type I interferons that are important
for host immune defense. This response serves the cell well in combating microbial infections but can also lead to autoim-
mune diseases. Chiu et al. now identify cytoplasmic RNA polymerase III as a DNA sensor that triggers interferon production.
The polymerase converts cytoplasmic DNA into 50-triphosphorylated RNA, which binds to and activates RIG-I to induce type I
interferons. These findings provide the identity of the sensor and resolve the long-standing
mystery of why cells maintain a cytoplasmic pool of RNA polymerase III.
MicroRNAs on Duty in Normal and Cancer Stem Cells
PAGE 592
Cancer stem cells provide certain cancer types with high tumorigenic capacity. Shimono et al.
now report that in cancer stem cells and in normal stem cells, three miRNA clusters are coor-
dinately downregulated. One of the downregulated miRNAs, miR-200c, controls the self-
renewal gene BMI1 and strongly suppresses the capacity for clonal expansion in normal and
malignant breast stem cells. These findings provide evidence that cancer stem cells and
normal stem cells share molecular mechanisms that regulate growth and differentiation.Cell 138, August 7, 2009 ª2009 Elsevier Inc. 407
